Cargando…
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
Pantothenate kinase-associated neurodegeneration, caused by mutations in the PANK2 gene, is an autosomal recessive disorder characterized by dystonia, dysarthria, rigidity, pigmentary retinal degeneration and brain iron accumulation. PANK2 encodes the mitochondrial enzyme pantothenate kinase type 2,...
Autores principales: | Brunetti, Dario, Dusi, Sabrina, Giordano, Carla, Lamperti, Costanza, Morbin, Michela, Fugnanesi, Valeria, Marchet, Silvia, Fagiolari, Gigliola, Sibon, Ody, Moggio, Maurizio, d’Amati, Giulia, Tiranti, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891449/ https://www.ncbi.nlm.nih.gov/pubmed/24316510 http://dx.doi.org/10.1093/brain/awt325 |
Ejemplares similares
-
Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model
por: Brunetti, Dario, et al.
Publicado: (2012) -
Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients
por: Santambrogio, Paolo, et al.
Publicado: (2015) -
Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts
por: Onesto, Elisa, et al.
Publicado: (2016) -
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
por: Chang, Xuting, et al.
Publicado: (2020) -
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
por: Viscomi, Carlo, et al.
Publicado: (2011)